Delayed Graft Function Terminated Phase 2 / 3 Trials for Medroxyprogesterone acetate (DB00603)

Also known as: Graft Function, Delayed

IndicationStatusPhase
DBCOND0004880 (Delayed Graft Function)Terminated2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs